Ensure cost-efficiency in your Multi-vessel Disease cases.

Multi-vessels coronary artery disease (CAD) is a disease stage in which at least two or three of the epicardial coronary arteries is involved with atherosclerosis of significant severity.

The goal in the treatment of multi-vessel disease is to reduce angina and heart failure symptoms.

The FAME study demonstrated that routine measurement of FFR (Fractional Flow Reserve) during DES-stenting in patients with multi-vessel disease is superior to current angiography guided treatment and improves outcome of PCI significantly.

From a short time, we also see some non Hyperemic index's been developed such as DFR™.  The goal of these indexs are to avoid injection of adenosine. It may reduce cost and duration procedure. It also may lead to assess patient who are contraindicated to FFR.